Pages that link to "Q31960701"
Jump to navigation
Jump to search
The following pages link to Clinical implications of circulating angiogenic factors in cancer patients (Q31960701):
Displaying 50 items.
- Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next? (Q26752752) (← links)
- Genotypic characteristics of resistant tumors to pre-operative ionizing radiation in rectal cancer (Q27007505) (← links)
- Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis (Q27026936) (← links)
- Hypoxia and VEGF mRNA expression in human tumors (Q28344471) (← links)
- Fibroblast growth factor signalling: from development to cancer (Q29616827) (← links)
- Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy. (Q30358961) (← links)
- Use of proximity ligation to screen for inhibitors of interactions between vascular endothelial growth factor A and its receptors (Q30844029) (← links)
- Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer (Q33331462) (← links)
- Bilateral downregulation of Nav1.8 in dorsal root ganglia of rats with bone cancer pain induced by inoculation with Walker 256 breast tumor cells (Q33581458) (← links)
- Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials (Q33633431) (← links)
- Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors (Q33636113) (← links)
- Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab. (Q33683918) (← links)
- Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer (Q33951007) (← links)
- Molecular mechanisms of cancer pain (Q33958925) (← links)
- Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies (Q34017735) (← links)
- In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors (Q34030193) (← links)
- Biomarkers for antitumor activity of bevacizumab in gastric cancer models (Q34138326) (← links)
- The application of genomic and molecular data in the treatment of chronic cancer pain (Q34207230) (← links)
- A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer (Q34224045) (← links)
- Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment (Q34268230) (← links)
- Usefulness of circulating vascular endothelial growth factor and neutrophil elastase as diagnostic markers of disseminated intravascular coagulation in non-cancer patients (Q34316762) (← links)
- Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer. (Q34450520) (← links)
- Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α. (Q34491398) (← links)
- MYC in breast tumor progression (Q34524915) (← links)
- Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications (Q34569994) (← links)
- Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers (Q34608643) (← links)
- The prognostic molecular markers in hepatocellular carcinoma (Q34668320) (← links)
- Putative role of 67 kDa elastin-laminin receptor in tumor invasion (Q34706663) (← links)
- Angiogenesis modulation in cancer research: novel clinical approaches (Q34742116) (← links)
- Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours (Q34762171) (← links)
- Platelets and cancer (Q34762260) (← links)
- Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer (Q34775716) (← links)
- PET for in vivo pharmacokinetic and pharmacodynamic measurements (Q34974991) (← links)
- The dual role of thymidine phosphorylase in cancer development and chemotherapy (Q34980526) (← links)
- Association between the Functional Polymorphism of Vascular Endothelial Growth Factor Gene and Breast Cancer: A Meta-Analysis (Q34990498) (← links)
- Bloodborne biomolecular markers in prostate cancer development and progression (Q35013211) (← links)
- Targeting angiogenesis in melanoma: prospects for the future (Q35076316) (← links)
- Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches (Q35165648) (← links)
- Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth (Q35256189) (← links)
- Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables (Q35257111) (← links)
- Aflibercept (VEGF Trap) in inoperable stage III or stage iv melanoma of cutaneous or uveal origin (Q35377689) (← links)
- Therapeutic advances in women's cancers (Q35418973) (← links)
- Antiangiogenesis: The Fifth Cancer Treatment Modality? (Q35577930) (← links)
- Tyrosine kinase inhibitors as cancer therapy (Q35589206) (← links)
- Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia (Q35609315) (← links)
- Angiogenesis in non-small cell lung cancer. A new target for therapy (Q35627784) (← links)
- Palm tocotrienols decrease levels of pro-angiogenic markers in human umbilical vein endothelial cells (HUVEC) and murine mammary cancer cells (Q35648921) (← links)
- Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis (Q35791487) (← links)
- Bevacizumab: an angiogenesis inhibitor with efficacy in colorectal and other malignancies (Q35798814) (← links)
- Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature (Q35810123) (← links)